Literature DB >> 7670655

Hereditary tumor syndromes of the nervous system: overview and rare syndromes.

D N Louis1, A von Deimling.   

Abstract

Hereditary tumor syndromes of the nervous system are a varied group of conditions that include neurofibromatosis 1, neurofibromatosis 2, tuberous sclerosis, and von Hippel-Lindau disease, as well as the retinoblastoma susceptibility, Li-Fraumeni, familial glioma, Turcot, Gorlin, Cowden and multiple endocrine neoplasia syndromes. For many of these conditions, the responsible genes have been localized or identified. Such studies have elucidated the genetic basis of both hereditary cancer predisposition and sporadic nervous system tumors. The first four hereditary tumors syndromes have been extensively studied and are discussed in detail in the four subsequent articles. The other syndromes have also been subject to both pathological and molecular genetic inquiries. In this introductory overview, we discuss the features common to the hereditary tumor syndromes of the nervous system, and review some of the rarer conditions.

Entities:  

Mesh:

Year:  1995        PMID: 7670655     DOI: 10.1111/j.1750-3639.1995.tb00588.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  11 in total

1.  Familiality in brain tumors.

Authors:  Deborah T Blumenthal; Lisa A Cannon-Albright
Journal:  Neurology       Date:  2008-09-23       Impact factor: 9.910

2.  Links between private habits, psychological stress and brain cancer: a case-control pilot study in France.

Authors:  Cécilia Cabaniols; Roch Giorgi; Olivier Chinot; Nabila Ferahta; Valérie Spinelli; Philippe Alla; Maryline Barrie; Marie-Pascale Lehucher-Michel
Journal:  J Neurooncol       Date:  2010-09-11       Impact factor: 4.130

3.  Genetic Variants of VEGF (rs201963 and rs3025039) and KDR (rs7667298, rs2305948, and rs1870377) Are Associated with Glioma Risk in a Han Chinese Population: a Case-Control Study.

Authors:  Jiannan Zhang; Jian Yang; Yuqing Chen; Qin Mao; Shanquan Li; Wenhao Xiong; Yingying Lin; Jie Chen; Jianwei Ge
Journal:  Mol Neurobiol       Date:  2015-06-21       Impact factor: 5.590

4.  Analysis of p53 tumor suppressor gene in families with multiple glioma patients.

Authors:  N Paunu; K Syrjäkoski; R Sankila; K O Simola; P Helén; M Niemelä; M Matikainen; J Isola; H Haapasalo
Journal:  J Neurooncol       Date:  2001-12       Impact factor: 4.130

Review 5.  Cellular and molecular pathology of medulloblastoma.

Authors:  J P Provias; L E Becker
Journal:  J Neurooncol       Date:  1996-07       Impact factor: 4.130

6.  Temozolomide: The evidence for its therapeutic efficacy in malignant astrocytomas.

Authors:  Ayman I Omar; Warren P Mason
Journal:  Core Evid       Date:  2010-06-15

Review 7.  Update on the management of familial central nervous system tumor syndromes.

Authors:  Andreas F Hottinger; Yasmin Khakoo
Journal:  Curr Neurol Neurosci Rep       Date:  2007-05       Impact factor: 5.081

8.  Elucidating the molecular pathogenesis of glioma: integrated germline and somatic profiling of a familial glioma case series.

Authors:  Daniel I Jacobs; Kazutaka Fukumura; Matthew N Bainbridge; Georgina N Armstrong; Spiridon Tsavachidis; Xiangjun Gu; Harsha V Doddapaneni; Jianhong Hu; Joy C Jayaseelan; Donna M Muzny; Jason T Huse; Melissa L Bondy
Journal:  Neuro Oncol       Date:  2018-11-12       Impact factor: 12.300

9.  Family history of cancer in benign brain tumor subtypes versus gliomas.

Authors:  Quinn T Ostrom; Christopher McCulloh; Yanwen Chen; Karen Devine; Yingli Wolinsky; Perica Davitkov; Sarah Robbins; Rajesh Cherukuri; Ashokkumar Patel; Rajnish Gupta; Mark Cohen; Jaime Vengoechea Barrios; Cathy Brewer; Cathy Schilero; Kathy Smolenski; Mary McGraw; Barbara Denk; Theresa Naska; Frances Laube; Ruth Steele; Dale Greene; Alison Kastl; Susan Bell; Dina Aziz; E A Chiocca; Christopher McPherson; Ronald Warnick; Gene H Barnett; Andrew E Sloan; Jill S Barnholtz-Sloan
Journal:  Front Oncol       Date:  2012-02-28       Impact factor: 6.244

10.  The association between antihypertensive drugs and glioma.

Authors:  M P W A Houben; J W W Coebergh; R M C Herings; M K Casparie; C C Tijssen; C M van Duijn; B H Ch Stricker
Journal:  Br J Cancer       Date:  2006-03-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.